Mayora Indah Tbk (MYOR)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 1,345.00 |
|---|---|
| 52-week range | 1,260.00 – 2,402.12 |
| Return, 1 month / 3 months | −10.6% / −25.1% |
| Return, 1 year / 3 years | −37.5% / −39.6% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 36.9% |
| Worst drawdown (1 year) | -44.0% |
| Average daily value traded | 19,312.54M IDR |
| Dividend yield | 4.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mayora Indah Tbk is an Indonesian food and beverage manufacturer based in Jakarta. The company makes biscuits, wafers, candies, chocolate products and instant coffee, and its brands include Kopiko and Beng Beng. Its customers are everyday consumers, and its products are sold through retailers and distributors in Indonesia and exported to markets abroad. Mayora Indah operates its own manufacturing plants and develops and markets its branded packaged foods.
The shares are listed on the Jakarta Exchange in Indonesia under the code MYOR, and the price on this page is in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mayora Indah Tbk (MYOR) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 1,345.00 on 19 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 392 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 37.5% and over the last three months it fell 25.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.2% | ||
| From 52-week high | -44.0% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -25.1% | ||
| 6-month return | -23.2% | ||
| 12-month return, skipping the last month | -30.0% | ||
| Risk (lower is better) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 36.9% | ||
| Worst drawdown (1 year) | -44.0% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 19,312.54M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.5% | ||
| Years with dividends | 5 |
Strengths
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | −10.6% |
| 3 months | −25.1% |
| 6 months | −23.2% |
| 1 year | −37.5% |
| 3 years | −39.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1,512.20 / 1,774.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 53.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jun 2026 | IDR 60.0000 |
| 19 Jun 2025 | IDR 55.0000 |
| 25 Jun 2024 | IDR 55.0000 |
| 22 Jun 2023 | IDR 35.0000 |
| 7 Jul 2022 | IDR 21.0000 |
| 3 Aug 2021 | IDR 52.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.